Ritu Soni

7PUBLICATIONS
2CO-AUTHORS
Toxicology (incl. clinical toxicology)PharmacogenomicsNeurology and neuromuscular diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 18, 2026
Phosphatidylinositol-3-kinase/Protein Kinase B (PI3K/AKT) and Nucleotide-Binding Oligomerization Domain-like Receptor Family Pyrin Domain Containing 3 (NLRP3) Inflammasome Modulation Underlies the Neuroprotective Effects of Vildagliptin in a Rotenone-Induced Mouse Model of Parkinson's Disease.

|Mar 24, 2025
Upregulation of the PI3K/AKT and Nrf2 Pathways by the DPP-4 Inhibitor Sitagliptin Renders Neuroprotection in Chemically Induced Parkinson's Disease Mouse Models.

Ritu Soni, Vaishali Pankaj, Sudeep Roy

|Feb 18, 2025
Dual GLP-1 and GIP Agonist Tirzepatide Exerted Neuroprotective Action in a Parkinson's Disease Rat Model.

Prashant Delvadia, Vipin Dhote, Avinash Singh Mandloi

|Dec 19, 2024
Hyperglycemia-Driven Insulin Signaling Defects Promote Parkinson's Disease-like Pathology in Mice.

Ritu Soni, Kirti Mathur, Hritik Rathod

|Sep 27, 2024
Decoding the Role of Nuclear Sirtuins in Parkinson's Pathogenesis.

Dishank Patel, Ritu Soni, Jigna Shah

|May 25, 2023
Uncovering Novel Therapeutic Targets for Parkinson's Disease.

Ritu Soni, Prashant Delvadia, Amit Joharapurkar

Pageof 2

Frequent Collaborators

5 joint publications

Jigna Shah

2 joint publications

Amit Khairnar